Little is known of health-relevant behaviour among long-term survivors of haematological disorders treated with haematopoietic SCT. This comparative cross-sectional multicentre study aimed (1) to explore the prevalence of selected behaviours in this group and (2) to compare them with those of the general population. Self-reported data of 376 survivors (mean age: 50.4 (s.d. = 12.8); median 7 years postallogeneic SCT (interquartile range (IQR) = 8.9; range 1-33) were compared with controls derived from the Swiss Health Survey 2007 by propensity score matching. Survivors were more physically inactive (26.8% vs 12.5%; P ⩽ 0.001) and consumed fewer portions of vegetables (⩾3 pieces: 10% vs 21.6%; P o 0.001), fruits (⩾3 pieces: 6.5% vs 10.6%; P o 0.001) and fish (31.2% vs 60.9% weekly fish dish; P o0.001). More survivors consumed dairy products daily (92.5% vs 62.9%; P o 0.001), used sun protection regularly (94.5% vs 85.3%, P o0.001) and had received influenza vaccinations in the past year (58.4% vs 21.5%; Po 0.001); fewer survivors smoked (13.4% vs 35.4%; P o 0.001). Survivors' weekly alcohol consumption was lower (median 1.5 servings (IQR 4) vs median 4.5 (IQR 10.3); P o 0.001). Of those taking immunosuppressants, 65.7% were non-adherent. Similar to the general population, survivors experience problems executing several health-enhancing behaviours, warranting corrective interventions.
INTRODUCTION
Haematopoietic SCT is an established treatment for patients with severe disorders of the haematopoietic system. Although many patients can be cured of their initial disease, up to two-thirds develop chronic conditions, including chronic GVHD (cGVHD), heart problems, endocrine disorders, neurocognitive impairment, musculoskeletal disorders and secondary malignancies. 1 As these conditions require lifelong management, 2 the majority of SCT survivors can be regarded being chronically ill. Research in chronic illness patients as well as in the general population indicates that favourable health behaviour prevents some chronic illnesses, delays progression of existing conditions and decreases mortality rates. 3 In particular, four health behaviours-adequate physical activity, healthy diet, non-smoking and moderate alcohol consumption-contribute to a longer, healthier life. 4 Ford et al. 3 large prospective study in the general population (N = 23 125) linked engagement in these behaviours with a reduced risk for early death from cancer and cardiovascular diseases. In Switzerland, cancer survivors, including SCT recipients, are therefore encouraged to follow the same national health recommendations for these four key health behaviours. [5] [6] [7] [8] [9] Additional recommendations include sun-protective measures, 10 scheduled vaccinations 11, 12 and close adherence to any medication regimen 13 (see also Table 1 for overview). While the literature on health behaviour in cancer survivors is growing, 14, 15 little is known about how many SCT survivors succeed in following a healthy lifestyle. Studies from the United States show that 29-36% of survivors exercised for at least 20-30 min three times per week compared with 30-45% of matched controls. 16, 17 Overweight was observed in 52% of survivors and 47% of controls, and only 5% of survivors reported eating a healthy diet, that is, one low in fat and high in fruits and vegetables. 17 Survivors were also less likely than controls to drink more than two servings of alcohol per day (15% vs 25%), 17 and high-risk drinking was less prevalent in survivors (9.5%) than in controls (13.3%). 18 In the reported studies, 7-14% of survivors currently smoked. [16] [17] [18] Survivors were more likely than controls to have received seasonal influenza vaccinations (59.7% vs 32.7%), especially those aged over 65 years (95% vs 73%). 17 To date, no study has examined sun-protective behaviours and medication intake in the long term following SCT. Further, knowledge is lacking as to whether health behaviour among European SCT survivors differ from those of the general population, and previous research focused on small sets of behaviours.
Therefore, the present study aimed
(1) to determine the prevalence of eight health behaviours in Swiss SCT survivors (that is, physical activity, dietary habits and weight control, alcohol intake, smoking, influenza vaccination, sun protection and medication adherence) (2) to compare Swiss SCT survivors' health behaviours with those of matched controls from the general population 1 Institute of Nursing Science, University of Basel, Basel, Switzerland; The use of sun-protective measures was assessed differently in the survivor population and the SHS; therefore, answers from survivors were recoded to allow comparison. SHS respondents were asked if they regularly apply sun-protective measures (yes/no). Survivors were asked how strictly they adhere to three sun-protective measures: using sunscreen, staying in shade between 10 and 16 h and wearing protective clothes (never, rarely, sometimes, often and always). Survivors' responses to the three questions were dichotomized (often and always = yes; never, rarely and sometimes = no). If at least one question was answered yes, a patient was categorized as using sun-protective measures regularly.
Vaccination (1 item)
•Receive a yearly influenza vaccination Received an influenza vaccination in the last year (yes/no).
Medication adherence (6 items)
•Adhere to your health-care professionals' recommendation with respect to timing, dosage and frequency of medication-taking during the prescribed length of time BAASIS (only measured in survivors) During the past 4 weeks, the BAASIS evaluates the different dimensions of non-adherent medication taking behaviour referring to the acknowledged ABC taxonomy which is described as followed: 23 Implementation of medication adherence: taking (omission of single doses), drug holidays (omission of successive doses), timing (deviation 42 h) on a six-point scale; and dose reduction (deviation from prescribed amount) (yes/no). Discontinuation (stopping treatment too early) is measured by one item (yes/no). Overall medication (non-)adherence is measured in two ways: dichotomously, that is, any self-reported medication non-adherence on any of the five aforementioned items is considered non-adherence; and continuously, indicating self-perceived overall medication adherence on a VAS ranging from 0% (never took medications as prescribed) to 100% (always took medications as prescribed). 24 Patients taking immunosuppressants received the full version of the BAASIS; those taking any other medications received adapted versions, which ask the same questions for any kind of oral medications and omits the timing dimension of medication intake. Content, concurrent and predictive validity of the BAASIS have been reported in solid organ transplantation 25, 26 Abbreviations: BMI = body mass index; BAASIS = Basel Assessment of Adherence with Immunosuppressive Medication Scale; VAS = Visual Analogue Scale.
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SUBJECTS AND METHODS Design
This cross-sectional comparative observational study is part of the mixedmethods multicentre PROVIVO project investigating Patient Reported Outcomes of long-term survivors after allogeneic SCT (NCT01275534). Data from the PROVIVO study and the 2007 Swiss Health Survey (SHS) were used. The PROVIVO study was approved by the Basel and Zürich ethical committees.
Setting, sample and data collection procedures
Convenience sampling was used to recruit allogeneic SCT recipients from the University Hospitals of Basel and Zurich from November 2011 until November 2012. Inclusion criteria were at least 1 year post transplantation and an age of at least 18 years. Exclusion criteria were an inability to read German, current hospitalization or a diagnosed end-of-life stage. Patients with visual and/or hearing impairment or severe psychiatric disorders (for example, suicidal tendencies, acute psychosis) were also excluded. In the month before their annual follow-up visits, a research assistant phoned all eligible SCT recipients, informed them about the study and inquired whether they were interested in participating. They were also asked if they were taking any type of immunosuppression medication. Those who were interested received the study information letter, an informed consent form and an appropriate questionnaire (version A for patients with immunosuppressants or version B for patients without) per postal mail. Patients returned the completed study materials to their treating physician at their annual follow-up visit or returned them via the post. Clinical and demographic data were collected from the transplant database and patient records. Data were anonymized and entered in a database.
Selection of case-matched controls from the SHS sample Propensity score matching was used to match each survivor with one control from the SHS. The following covariates were matched: gender, age, education and residence, that is, the Swiss region (seven regions) and urbanization zone (nine types) of residence. 20 Each propensity score value was allocated a score between 0 and 1 to express the probability of one participant having a perfect match when their observable characteristics are given. Using the minimum distance method, each patient was linked to the control group subject with the nearest propensity score value. 21 The area under the curve (c-statistic) of the logistic model to calculate the propensity scores was 0.74 (95% confidence interval = 0.72-0.76), indicating appropriate matching.
Variables and measurement
Sociodemographic and clinical data. The following sociodemographic variables were documented for both patients and controls: gender, age, education (compulsory schooling, secondary education, tertiary education), Swiss living region and urbanization zone (not displayed in this article), partnership (married or cohabiting/single or not cohabiting) and employment (full-time (working ⩾ 80%), part-time or not used). Table 2 gives an overview about the clinical characteristics of SCT survivors.
Health behaviours assessed in survivors and in SHS population. To allow comparison with the general population, health behaviours were measured with standardized questions, almost all of which were drawn from the SHS. Ongoing data quality controls concerning item clarity and validity were performed by the Swiss Federal Statistical Office. 19 Table 1 
Data analysis
Descriptive statistics included frequencies, percentages and proportions, means and s.d.'s, or medians and interquartile ranges (IQR). Missing data were excluded pairwise for the statistical analysis. Clinical characteristics of respondents and non-respondents in the SCT sample were compared using independent t-tests, χ 2 tests and the Mann-Whitney U-test. To compare the prevalence of health behaviours in survivors with those of their matched SHS subjects, we used McNemar's or Wilcoxon's signed-rank paired testing methods as appropriate. 27, 28 Influenza vaccination rates were compared between the survivor and control groups, including a subgroup analysis comparing survivors with controls over the age of 65 years, for whom a yearly influenza vaccine is recommended. 12 All calculated P-values were adjusted (upwards) to correct for multiple testing. To limit the expected number of false-positive findings with an α-level of 0.05 to below 5%, we used the false discovery rate procedure (reported as q-values in tables). 28 Analyses were performed with IBM SPSS software version 21 (IBM Inc., Armonk, NY, USA) and SAS version 9.3.1. Graded according to the National Institutes of Health consensus criteria for cGVHD. 49 
RESULTS
Characteristics of survivors and controls
Of the 638 survivors identified as eligible, 610 (95.6%) were contacted successfully. Of these, 376 (61.6%) were included in the final sample for analysis (Figure 1) . Compared with all nonparticipants (those unreachable, withdrawn from the study or declined), participants were more likely to be older at the date of transplantation (aged 41.3 (s.d. 14.5) vs 36.9 (16.5) years; Po 0.03), and to be at an early follow-up stage (median follow-up 7.1 (range 1-33) vs 9.0 (range 1-35) years; P o 0.01).
Among survivors, 39.6% showed some form of cGVHD, but most (84.2%) were highly functional (Karnofsky index score ⩾ 90%). The primary disease was active in 5.2% (Table 2) . Table 3 compares the demographic characteristics of survivors and controls. More survivors were married or cohabiting (78.3% vs 67.2%, P o 0.001); fewer had a full-time employment (34.6% vs 53.1%), and in contrast more than double a part-time job (33.8% vs 14.4%); whereas the proportion of individuals not working was similar in both groups.
Comparison of health behaviours between survivors and controls Table 4 summarizes the health behaviours of survivors and their controls. Compared with the general population, survivors were more likely to report inactivity (26.8% vs 12.5%, P o 0.001). Only 11.2% of survivors had the recommended five servings of fruits and vegetables per day, in contrast to 24.2% of controls (P o 0.001). Survivors were less likely to have at least one weekly serving of fish (31.2% vs 60.9%; P o0.001). Compared with controls, fewer survivors ate meat on more than 5 days per week (17.8% vs 26.6%; P o0.001) and more consumed dairy products on a daily basis (92.5% vs 62.9%; P o0.001). No significant differences arose in BMI distribution. Overweight and obesity were present in 26.4% and 10.2%, respectively, of survivors and 29.4% and 12.4%, respectively, of controls. Survivors reported consuming significantly lower numbers of alcoholic beverages per week (median 1.5 (IQR 4) vs 4.5 (IQR 10.3); P o 0.001), yet critical amounts of alcohol (that is, 421 standard beverages per week for men, 14 for women) were consumed by 14 survivors (3.7%; 8 men, 6 women). Despite reporting similar rates of ever having smoked, significantly fewer survivors currently smoked (13.4% vs 35.4%; Po P o 0.001). Survivors made more regular use of sun protection (94.1% vs 85.3%; P o 0.001)-the most common method being sunscreen (with 79.1% using it often or always), followed by staying in shaded areas between 10.00-16.00 h (73.6%) and wearing sun-protective clothes (71.1%). Survivors (58.4%) were more likely than controls to have received influenza vaccinations (21.5%); this was also true for the 56 survivors over the age of 65 years compared with their matched controls, for whom the vaccine was also recommended (76.8% vs 32.3%; P = 0.002).
Medication non-adherence in patients taking immunosuppressants or other medications Of 376 participants, 107 required no medications and 170 required non-immunosuppressant medications. The remaining 99 were using immunosuppressants, of whom 65 (65.7%) reported nonadherence to at least one dimension of their medication regimens. Non-adherence in the implementation of the prescribed medical regimens was observed in 64 patients (64.6%). Thirty-three (33.3%) had failed to take at least one dose in the past 4 weeks and 61.2% had had timing deviations of more than 2 h. Four (4.1%) reported having reduced their dosages without consulting a physician and three (3.2%) had taken drug holidays. Further three patients had stopped their immunosuppressant intake early and were therefore regarded as non-persistent with the therapy. The median selfperceived overall adherence (reported via the VAS) was 95.0% (IQR: 15).
One hundred and seventy patients took non-immunosuppressant medications. For this group, the 4-week prevalences of the four measured dimensions of non-adherence (taking nonadherence, dose reduction, drug holidays and non-persistence) were 37.6%, 7.3%, 12% and 2.4%, respectively. Their average VAS rating for self-perceived adherence was 98.0% (IQR 5).
DISCUSSION
To our knowledge, this is the first study to compare a comprehensive set of health behaviours in SCT survivors with those of matched controls. We observed that survivors were more likely to be inactive, and showed more unfavourable nutrition habits with regard to vegetable, fruit and fish consumption. However, survivors were less likely to be current smokers and drank less alcohol. They were also more likely to receive influenza Health behaviours after SCT M Kirsch et al vaccinations and to protect themselves from UV radiation. Our findings indicate that, overall, survivors engage less often in active health behaviours (for example, physical activity and dieting) aimed at preventing new diseases. However, they more often avoid health-impairing habits such as smoking and drinking. These innovative insights warrant evaluation in the light of existing evidence. Although the proportion of active individuals is similar in both groups, twice as many patients were inactive compared with matched controls. The following hypotheses might explain these low percentages: many survivors suffered from some form of cGVHD and certainly from various other late effects, potentially inhibiting their physical performance. 29 Moreover, many survivors complain about fatigue, which can persist far beyond treatment. Interestingly, although fatigue is a barrier to exercise, it can be reduced by regular physical activity. 30 Therefore, given that recent research has showed that regular activity not only reduced fatigue but might also attenuate the risk of developing diabetes and cardiovascular conditions (including hypertension) after SCT, 31, 32 interventions are needed to improve survivors' physical activity.
Another health behaviour that might lower the risks of comorbidities such as diabetes and dyslipidaemia is a diet rich in fruits and vegetables. 32 Although consistent with earlier reports showing that cancer survivors often fail to adhere to dietary guidelines, 33 the low fruit and vegetable intake in our study is particularly worrisome. To some extent, our findings concerning dietary habits might be linked to oral cGVHD-related factors such as xerostomia, mucosal and hypopharyngeal inflammation (which cause painful burning sensations in the mucous membranes).
Other late effects such as dental problems might cause problems with chewing and swallowing food, which might explain the lower meat consumption. Further reasons for dietary intolerances or aversions might be food allergies, taste changes, medicationrelated nausea or a low-bacteria diet (for example, avoiding raw seafood and vegetables). 34, 35 Mean BMIs did not differ significantly between survivors and controls, indicating that overweight and obesity in survivors are as common as in the general population. Since the 1990s, obesity has almost doubled in the Swiss population, 36 and also appears problematic in the survivor group, potentially increasing the risks of several complications and non-relapse mortality. 37, 38 Using focus group interviews, Jim et al. 39 showed that survivors desire more information regarding post transplant quality of life aspects and in particular with regard to late complications, as these often arise unexpectedly and threaten the ongoing sense of recovery. Giving information about potential benefits of healthier lifestyle choices should be also an integral part of survivor care. Admittedly, at the time of data collection, no comprehensive lifestyle counselling was included in either of the two hospitals' follow-up services. The higher dairy product consumption in our survivor sample remains difficult to explain. One possibility is that beneficial effects of dairy products on skeletal and dental health might have been delivered more frequently (although in a non-standardized manner), yet this is only a hypothesis.
More than three-quarters of our participants reported regular use of sun-protective measures-a proportion much higher than in the matched control group. Survivors also seem to be more aware of this factor than solid organ transplant groups, among which only one-third of patients wear protective clothing and twothirds regularly use sunscreen. 40 Also, survivors were less likely than their controls to smoke: a substantial number had quit smoking. Nevertheless, while consistent with previous research (7-13%), [16] [17] [18] the prevalence of smokers is still problematic, given the known relationship between smoking and the high risk for malignancies due to exposure to alkylating agents, bleomycin, radiation, TBI and cGVHD. 41 Therefore, regular smoking cessation programs should be offered.
Unfortunately, our study revealed a high rate of immunosuppressive non-adherence (65.7%). This prevalence is higher than numbers found in solid organ transplant groups, although comparisons are complicated by differences in operational definitions and measurement methods. 42 Evidence from solid organ transplantation has linked even minimal deviations from the prescribed medication schedule (45%) to negative clinical consequences (for example, graft loss, rejection). 43, 44 This underpins our stringently chosen cutoff for non-adherence. However, a clear need exists for further research identifying a clinically meaningful definition for medication non-adherence in SCT. Hence, a prospective study is recommended to assess the impact of subclinical medication non-adherence on clinical outcome, especially in terms of cGvHD. The influenza vaccination rate among our participants was higher than in the normal population. However, it is not yet satisfactory given that influenza may cause severe disease and mortality in SCT survivors. As patients' motivation to vaccinate might depend on the practice patterns of their transplant centres, transplant teams should actively educate them and their families. The findings of this cross-sectional study allow no causal relationships and must be interpreted in the context of potential limitations. For example, we used survey data with the potential One alcoholic beverage = 3 dL beer or 1 dL wine or 4 cL spirits or liquor.
Health behaviours after SCTto underestimate true health behaviour prevalences. Socially undesirable behaviours such as smoking are prone to underreporting-particularly in a cancer survivor population, in which smoking is mostly undesirable. 45 Only German-speaking patients participated, as the questionnaire was only available in this language. To enhance the participation of high-risk foreign language speakers, 46 we recommend using multilingual questionnaires and the assistance of professional translators as appropriate. Additionally, hospitalized patients were not included. Therefore, it is possible that those who participated were in better physical condition, making them more likely to engage in health behaviours such as physical activity. Also, we did not ask patients taking immunosuppressants (IS) about their adherence to other medications; therefore, it remains unclear whether differences exist in their taking behaviour between IS and other medication. A future study should examine medication taking behaviour regarding the entire medical regimen, optimally triangulating patient self-report with other vigorous assessment methods such as electronic monitoring, blood assay and physician estimation.
Despite these limitations, this study had the strength of a casematched control design. Even taking into account the low prevalence (that is, lower than the OECD (Organization for Economic Co-operation and Development) average) 47 of unhealthy behaviours in Switzerland's general population, this allows a sound comparison with other European populations. In the context of the growth and increasing longevity of the SCT survivor population, our work has several important clinical implications. First, given the high prevalence of suboptimal health behaviours, regular screening throughout follow-up is warranted, and preventive and remediating strategies are indicated. It is crucial to recognize this population's health behaviour practices and to use the information from this and other studies both to assist survivors with their disease self-management practises, and to allow practitioners to develop accurately targeted behavioural interventions. In particular, physical inactivity, poor nutritional practises, medication non-adherence and lack of influenza vaccinations were problematic in our group. Interventions on physical activity and diet have been tested in cancer survivors, including SCT recipients, resulting in observable short-and medium-term improvements in health behaviours. 48 Further investigations are needed to examine the relationship between programs' content and delivery and their sustainable effects on clinical outcomes.
CONCLUSIONS
This study provides population-based measures of health behaviours among SCT survivors in Switzerland. Survivors are most likely to adopt beneficial health behaviours regarding not smoking and low alcohol consumption. Yet, relative to the general population, a considerable group still engage in unfavourable behaviours. Our findings indicate a need for investigating the effectiveness of interventions to increase survivors' positive health behaviours, including medication adherence.
